Skip to main content

. 1959 Mar;12(2):163–169. doi: 10.1136/jcp.12.2.163

THE SENSITIVITY OF STAPHYLOCOCCI AND OTHER WOUND BACTERIA TO ERYTHROMYCIN, OLEANDOMYCIN, AND SPIRAMYCIN

E J L Lowbury ¹, L Hurst ¹

PMCID: PMC479882 PMID: 13641436

163

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

FINLAND M., JONES W. F., Jr, NICHOLS R. L. Development of resistance and cross-resistance in vitro to erythromycin, carbomycin, spiramycin, oleandomycin and streptogramin. Proc Soc Exp Biol Med. 1956 Nov;93(2):388–393. doi: 10.3181/00379727-93-22766. [DOI] [PubMed] [Google Scholar]
GARROD L. P. The erythromycin group of antibiotics. Br Med J. 1957 Jul 13;2(5036):57–63. doi: 10.1136/bmj.2.5036.57. [DOI] [PMC free article] [PubMed] [Google Scholar]
GERACI J. E., NEEDHAM G. M. Laboratory studies of oleandomycin (matromycin). Antibiotic Med Clin Ther (New York) 1956 Oct;3(5):334–335. [PubMed] [Google Scholar]
HUDSON D. G., YOSHIHARA G. M., KIRBY W. M. Spiramycin; clinical and laboratory studies. AMA Arch Intern Med. 1956 Jan;97(1):57–61. doi: 10.1001/archinte.1956.00250190073005. [DOI] [PubMed] [Google Scholar]
LOWBURY E. J. L., TOPLEY E. Chemotherapy for staphylococcus aureus in burns. Lancet. 1952 May 24;1(6717):1036–1042. doi: 10.1016/s0140-6736(52)90693-4. [DOI] [PubMed] [Google Scholar]
LOWBURY E. J. Chemotherapy for Staphylococcus aureus; combined use of novobiocin and erythromycin and other methods in the treatment of burns. Lancet. 1957 Aug 17;273(6990):305–310. doi: 10.1016/s0140-6736(57)92205-5. [DOI] [PubMed] [Google Scholar]
WILLIAMS R. E. O., RIPPON J. E. Bacteriophage typing of Staphylococcus aureus. J Hyg (Lond) 1952 Sep;50(3):320–353. doi: 10.1017/s002217240001963x. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES